Investing

First Look Analysts Research Calls for Monday, March 13

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. https://briefing.com

Upgrades:

> Amgen (AMGN) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $265

> Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $375

> JPMorgan Chase (JPM) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $155

> Moderna (MRNA) upgraded to Outperform from Market Perform at TD Cowen; tgt raised to $180

> SAGE Therapeutics (SAGE) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $60

Downgrades:

> Allbirds (BIRD) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $1.50

> British American Tobacco (BTI) downgraded to Neutral from Overweight at JP Morgan

> Comerica (CMA) downgraded to Hold from Buy at Odeon

> Hercules Capital (HTGC) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt lowered to $10.50

> KeyCorp (KEY) downgraded to Hold from Buy at Odeon

> Logitech Int’l SA (LOGI) downgraded to Neutral from Outperform at Credit Suisse

> Merck (MRK) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $115

> Wells Fargo (WFC) downgraded to Hold from Buy at Odeon

Others:

> Cabot (CBT) initiated with an Outperform at Credit Suisse; tgt $94

> GE HealthCare (GEHC) initiated with an Outperform at Evercore ISI; tgt $90

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.